FDA seeks feedback on generative AI regulations - MedTech Dive
Reported by MedTech Dive · all stories from medtechdive.com
Editorial digest
The U.S. Food and Drug Administration is seeking public feedback. This input will help shape potential regulations for generative artificial intelligence. These regulations will specifically pertain to medical devices.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at MedTech Dive →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/18/2026
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices | AHA News - American Hospital Association
The FDA seeks input on regulating generative AI for medical devices.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Trusted health newsroom8/20/2026
FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
The FDA is deliberating its regulatory strategy for generative AI medical devices.
- Reputable trade press8/19/2026
FDA Opens Comment Period on GenAI Device Regulation - Medical Device and Diagnostic industry
The FDA is seeking public comments on generative AI regulation in medical devices.
- Trusted health newsroom8/18/2026
FDA considering doctor-like assessment for AI-enabled devices - Axios
The FDA is considering a doctor-like assessment method for AI-enabled medical devices.
- Reputable trade press8/20/2026
FDA-cleared medical AI rarely tested for real-world benefits - News-Medical
FDA-cleared medical AI often lacks real-world benefit testing.